Shopping Cart
- Remove All
Your shopping cart is currently empty
Odesivimab (REGN-3471) is a human monoclonal antibody targeting the Zaire strain of Ebola virus, with potential antiviral activity, used for research on Ebola virus infection.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $247 | In Stock | |
| 5 mg | $645 | In Stock | |
| 10 mg | $987 | In Stock | |
| 25 mg | $1,530 | In Stock | |
| 50 mg | $1,980 | In Stock |
| Description | Odesivimab (REGN-3471) is a human monoclonal antibody targeting the Zaire strain of Ebola virus, with potential antiviral activity, used for research on Ebola virus infection. |
| In vitro | Odesivimab, Atoltivimab and Maftivimab can be combined to form REGN-EB3 with an IC50 value of 0.39 nM, which can be used for Ebola virus research. Odesivimab showed specific binding to soluble viral glycoprotein. [1] |
| In vivo | Odesivimab with Atoltivimab and Maftivimab (REGN-3471, 50 mg/kg) were protective against Ebola virus infected rhesus monkey models. [1] |
| Synonyms | REGN-3471, REGN3471 |
| Cas No. | 2135632-30-1 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.